BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 16, 2000
View Archived Issues
Advanced Tissue Sciences restructures joint venture for Dermagraft during Q4
Read More
Lundbeck highlights significant events during 1999
Read More
Lilly files NDA for new formulation of Prozac for depression
Read More
IND filed by NeoPharm for glioblastoma treatment
Read More
Isotechnika receives Canadian approval for human testing of immunosuppressive drug
Read More
CytRx to continue Flocor development as treatment for sickle cell disease
Read More
Aventis launches new antibiotic in Canada
Read More
Anesta renegotiates U.S. marketing rights for Actiq with Abbott
Read More
Multiple-dose clinical study of Betabloc as Alzheimer's therapy to begin soon
Read More
EGF receptor tyrosine kinase inhibitor selected for clinical testing at Parke-Davis
Read More
Otsuka prepares new orally active analgesic agents
Read More
Maleimide PKC inhibitors designed by Japan Tobacco
Read More
New agents for insulin resistance syndrome in the Merck pipeline
Read More
Meiji Seika discloses wide series of carbapenems and orally bioavailable esters
Read More
Neurocrine Biosciences' GnRH antagonist program advances
Read More
Rhein Biotech aims to become a world leader in vaccines with GCV acquisition
Read More
Selective glucocorticoid receptor modulators discovered by Abbott
Read More
Ampakine-like compounds for psychiatric and neurological disorders
Read More
Antiepileptic agents under study at Arzneimittelwerk Dresden
Read More
Potent, selective c-Src TK inhibitor identified using new target-based method
Read More
BOM-1006 selected as a lead benzimidazole for the development of antiallergic agents
Read More
Schering-Plough to copromote Tequin in U.S.; Tequin evaluated in PROVE IT trial
Read More
New use for teprenone in myocardial preconditioning? Evidence presented at ACC meeting
Read More
Continued treatment with Enbrel safe and effective in chronic heart failure
Read More
Nicostatin effective for increasing "good" cholesterol, lowering "bad" cholesterol
Read More
Monsanto and Pharmacia & Upjohn proceed towards completion of merger
Read More
Novel features of H-345/52 indicate promising activity in tachyarrhythmia
Read More